Viagra experienced no impact on saquinavir pharmacokinetics. A stronger CYP3A4 inhibitor for example ketoconazole or itraconazole may very well be envisioned to acquire increased influence than that observed with saquinavir. Populace pharmacokinetic knowledge from sufferers in medical trials also indicated a reduction in sildenafil clearance when i